ECSP003590A - CALCIOLITIC COMPOUNDS - Google Patents

CALCIOLITIC COMPOUNDS

Info

Publication number
ECSP003590A
ECSP003590A EC2000003590A ECSP003590A ECSP003590A EC SP003590 A ECSP003590 A EC SP003590A EC 2000003590 A EC2000003590 A EC 2000003590A EC SP003590 A ECSP003590 A EC SP003590A EC SP003590 A ECSP003590 A EC SP003590A
Authority
EC
Ecuador
Prior art keywords
calciolitic
compounds
bones
disorders
new methods
Prior art date
Application number
EC2000003590A
Other languages
Spanish (es)
Inventor
Maxine Gowen
Larry S Suva
John Fox
George B Stroup
Edward F Nemeth
Original Assignee
Smithkline Beecham Corp
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Nps Pharma Inc filed Critical Smithkline Beecham Corp
Publication of ECSP003590A publication Critical patent/ECSP003590A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se proporcionan nuevos métodos para tratar enfermedades o transtornos de los huesos.New methods are provided to treat diseases or disorders of the bones.

EC2000003590A 1999-07-31 2000-07-28 CALCIOLITIC COMPOUNDS ECSP003590A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14677899P 1999-07-31 1999-07-31

Publications (1)

Publication Number Publication Date
ECSP003590A true ECSP003590A (en) 2002-02-25

Family

ID=22518969

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2000003590A ECSP003590A (en) 1999-07-31 2000-07-28 CALCIOLITIC COMPOUNDS

Country Status (21)

Country Link
EP (1) EP1200076A4 (en)
JP (1) JP2003505502A (en)
KR (1) KR20020016928A (en)
CN (1) CN1367687A (en)
AU (1) AU764716B2 (en)
BR (1) BR0012921A (en)
CA (1) CA2380081A1 (en)
CO (1) CO5180628A1 (en)
CZ (1) CZ2002360A3 (en)
EC (1) ECSP003590A (en)
HK (1) HK1046238A1 (en)
HU (1) HUP0202167A3 (en)
IL (1) IL147875A0 (en)
MX (1) MXPA02001204A (en)
NO (1) NO20020466L (en)
PE (1) PE20010459A1 (en)
PL (1) PL353318A1 (en)
TR (1) TR200200278T2 (en)
UY (1) UY26265A1 (en)
WO (1) WO2001008673A1 (en)
ZA (1) ZA200200784B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030018203A1 (en) 2002-07-17 2003-01-23 Largo Maria Amparo Calcilytic compounds
MY159417A (en) * 2000-01-24 2017-01-13 Smithkline Beecham Corp Calcilytic compounds
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
AR042132A1 (en) 2002-11-26 2005-06-08 Smithkline Beecham Corp COMPOUND OF 2- HYDROXI -3- (2- ARIL - 1, 1 - DIMETHYLETHYLAMINE) PROPOXIFENILO, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS AND USES IT TO PREPARE IT
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
TW200845956A (en) 2006-12-18 2008-12-01 Smithkline Beecham Corp Calcilytic compounds
EP2797591A1 (en) * 2011-12-27 2014-11-05 Ubaldo Armato Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
CN108420814A (en) * 2017-02-15 2018-08-21 四川大学 A kind of NPS-2143 is used for the new application of antibacterial
CN116173187B (en) * 2023-03-14 2024-05-10 哈尔滨医科大学 Application of calcitonin in preparation of medicine for preventing and treating restenosis in stent, medicine coating stent and preparation method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA002984B1 (en) * 1996-04-09 2002-12-26 Эн Пи Эс Фармасьютикалз, Инк. Calcilytic compounds, pharmaceutical compositions and method of screening for calcilytic compounds
AR014975A1 (en) * 1998-04-08 2001-04-11 Nps Pharma Inc CALCILITICAL COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM, AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
AR018177A1 (en) * 1998-04-08 2001-10-31 Smithkline Beecham Corp CALCILITICAL COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.

Also Published As

Publication number Publication date
HUP0202167A3 (en) 2006-07-28
AU6504100A (en) 2001-02-19
KR20020016928A (en) 2002-03-06
NO20020466L (en) 2002-03-20
ZA200200784B (en) 2003-01-29
UY26265A1 (en) 2001-03-16
EP1200076A4 (en) 2005-02-09
CN1367687A (en) 2002-09-04
TR200200278T2 (en) 2002-06-21
PL353318A1 (en) 2003-11-17
CZ2002360A3 (en) 2002-10-16
PE20010459A1 (en) 2001-06-11
WO2001008673A1 (en) 2001-02-08
EP1200076A1 (en) 2002-05-02
JP2003505502A (en) 2003-02-12
IL147875A0 (en) 2002-08-14
CO5180628A1 (en) 2002-07-30
CA2380081A1 (en) 2001-02-08
MXPA02001204A (en) 2004-05-21
HK1046238A1 (en) 2003-01-03
NO20020466D0 (en) 2002-01-29
AU764716B2 (en) 2003-08-28
BR0012921A (en) 2002-06-18
HUP0202167A2 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
DK2052714T3 (en) Topical gel feeding system for the treatment of skin disorders
DE60124302D1 (en) THIAZONE DERIVATIVES FOR THE TREATMENT OF PPAR-LIFE DISEASES
ATE275145T1 (en) CHINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMORS
PT967214E (en) INTRANASAL FORMULATIONS FOR THE TREATMENT OF SEXUAL DISORDERS
CU23029A3 (en) BENZOPIRAN REPLACED ANALOGS FOR THE TREATMENT OF INFLAMMATION
DK1206474T3 (en) Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
PT977748E (en) SUBSTITUTED BENZOPIRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION
UY26130A1 (en) COMPOUNDS TO TREAT OBESITY
NO20005884D0 (en) Combination therapy for the treatment of bipolar disorders
DE60021381D1 (en) CHINONIC COMPOUNDS FOR THE TREATMENT OF DISEASES
PT1206436E (en) RETINOIDS FOR THE TREATMENT OF ENFISEMA
DE502004010131D1 (en) PYRIDOPYRIMIDINONE FOR THE TREATMENT OF CANCER DISORDERS
SE9901077D0 (en) Novel use
ECSP003590A (en) CALCIOLITIC COMPOUNDS
DK0971922T3 (en) Tetrahydropyrido compounds
NO20014241D0 (en) C16-unsaturated FP-selective prostaglandin analogs
SE9801494D0 (en) Novel use
PT983275E (en) NEW DERIVATIVES OF TRIPTOLIDO ADVANTAGES FOR THE TREATMENT OF AUTOMATIC DISEASES
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
IS5951A (en) 5HT1 antidepressant for the treatment of depression
YU60101A (en) Resorcinol derivatives
TR200101693T2 (en) Treatment of follicular lymphomas using inhibitors of the lysophoxin (LT) expression pathway.
BRPI0408117A (en) bifunctional heterocyclic compounds and methods of production and use thereof
ATE428429T1 (en) PROSTAGLANDINS FOR THE TREATMENT OF LIGHT RADIATION EYE DISEASES SUCH AS PHOTORETINITIS
PT1268482E (en) PIRANOINDOIS FOR THE TREATMENT OF GLAUCOMA